Study to Determine if AZD0284 is Effective and Safe in Treating Plaque Psoriasis
Status:
Terminated
Trial end date:
2018-04-18
Target enrollment:
Participant gender:
Summary
The Sponsor is developing the study drug, AZD0284, for the potential treatment of Plaque
psoriasis. Psoriasis is a skin condition that causes red, flaky, crusty patches of skin
covered with silvery scales. The severity of the disease varies, but in many cases it can
have a major impact on their quality of life if not adequately treated.
The purpose of the study is to determine the short term safety, pharmacodynamic and clinical
effect of AZD0284 in patients with psoriasis.